Pharmacokinetic/Pharmacodynamic Study of MP-513 in Japanese Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 08 Apr 2013
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 01 Nov 2012 Primary endpoint '2 hour postprandial glucose level' has been met according to results published in the Diabetes, Obesity and Metabolism.
- 01 Nov 2012 Results published in the Diabetes, Obesity and Metabolism.
- 04 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History